Nuclear Medicine Market Size, Application Analysis Emerging Technologies and Forecast 2030

Nuclear Medicine Market: Global Industry Analysis and Forecast (2024-2030)

Global Nuclear Medicine Market to Reach USD 18.87 Billion by 2030, Growing at a CAGR of 14.7%

Summary:

The global Nuclear Medicine Market, valued at USD 7.22 billion in 2023, is poised for significant growth. According to recent analysis, the market is expected to expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2030, reaching approximately USD 18.87 billion. This growth is driven by advancements in nuclear medicine technology, increased adoption in oncology and neurology, and rising investments in research and development.

 

Request Your Complimentary Sample Here. Get started today! https://www.maximizemarketresearch.com/request-sample/98418/ 

Market Size

The Nuclear Medicine Market is set to witness robust growth, with a valuation of USD 7.22 billion in 2023. The market is projected to grow at a CAGR of 14.7% from 2024 to 2030, achieving an estimated USD 18.87 billion by the end of the forecast period. This growth reflects the increasing demand for advanced diagnostic and therapeutic solutions in the healthcare sector.

Overview

The Nuclear Medicine Market research report provides a comprehensive analysis of the market's current status and future prospects. The study evaluates the market's dynamics, including key drivers, challenges, and opportunities, while examining the impact of recent innovations and strategic developments by leading players.

Market Scope

The research employs both primary and secondary methodologies to offer a thorough examination of the Nuclear Medicine Market. It provides insights into market dynamics such as supply-demand imbalances, pricing trends, and consumer preferences. The data is analyzed using advanced forecasting techniques to predict market trends through 2030.

Segmentation

The Nuclear Medicine Market is segmented as follows:

  • By Product Type:

    • Diagnostic Radiotherapeutics
    • Therapeutic Radiotherapeutics
  • By Application:

    • Neurology
    • Oncology
    • Cardiology
    • Others
  • By Modality:

    • SPECT
    • PET
    • Alpha-emitters
    • Beta-emitters
    • Brachytherapy
  • By Procedures:

    • Oncology
    • Cardiovascular
    • Central Nervous System
    • Endocrine
    • Skeletal
    • Gastrointestinal
    • Genito-urinary
    • Pulmonary
    • PET & PET-CT
    • Therapeutic
    • Others
  • By End-User:

    • Hospitals
    • Clinical Laboratories
    • Diagnostic Centers
    • Others

Major Manufacturers

Key players in the Nuclear Medicine Market include:

  • Cardinal Health Inc. (US)
  • GE HealthCare Technologies Inc. (US)
  • Jubilant Lifesciences (US)
  • Lantheus Medical Imaging Inc. (US)
  • Biodex Medical Systems, Inc. (US)
  • Standard Imaging Inc. (US)
  • Digirad Corporation (US)
  • CMR Naviscan (US)
  • Nordion Inc. (Canada)
  • Bayer AG (Germany)
  • Siemens Healthineers (Germany)
  • SurgicEye GmbH (Germany)
  • Curium (France)
  • Advanced Accelerator Applications (France)
  • Mallinckrodt Pharmaceuticals (UK)
  • Bartec Technologies Ltd. (UK)
  • Norgine B.V. (Netherlands)
  • Medtronic plc (Ireland)
  • DDD-Diagnostic A/S (Denmark)
  • Mediso Ltd. (Hungary)
  • Neusoft Corporation (China)
  • Canon Medical Systems Corporation (Japan)
  • FUJIFILM Holdings Corporation (Japan)
  • Cyclopharm (Australia)
  • Bozlu Holding A.Ş (Turkey)

Regional Analysis

The market analysis covers five major regions: North America, Europe, Asia-Pacific, the Middle East & Africa, and South America. Each region is evaluated for market size, growth potential, and emerging trends, with forecasts extending to 2030. The study highlights regional variations in market dynamics and provides insights into growth drivers and challenges specific to each area.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a notable impact on the Nuclear Medicine Market, influencing supply chains and altering healthcare priorities. The pandemic accelerated the adoption of remote diagnostics and telemedicine, while also highlighting the need for robust healthcare infrastructure and innovation.

Key Questions Answered

  • What are the high-growth opportunities in the Nuclear Medicine Market by product type, end-user, and region?
  • Which market segments are expected to expand the fastest, and why?
  • Which regions are projected to grow more rapidly, and what are the driving factors?
  • What are the primary drivers and challenges for the Nuclear Medicine Market?
  • What business risks and threats are associated with the market?

Table of Contents:

  1. Overview
  2. Global Market Status and Forecast by Regions
  3. Global Market Status and Forecast by Types
  4. Global Market Status and Forecast by Downstream Industry
  5. Market Driving Factor Analysis
  6. Market Competition Status by Major Manufacturers
  7. Major Manufacturers Introduction and Market Data
  8. Upstream and Downstream Market Analysis
  9. Cost and Gross Margin Analysis
  10. Marketing Status Analysis
  11. Market Report Conclusion
  12. Research Methodology and Reference

For further details, feel free to reach out to us at any time: https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-market/98418/ 

About Us:

Maximize Market Research is a premier market research and business consulting firm that delivers actionable insights across various industries. Our expertise extends to IT and telecom, chemicals, food and beverage, aerospace and defense, and healthcare sectors. We are committed to providing in-depth analyses and strategies that drive growth and innovation for our global clients.

Explore additional related reports for more insights and information: 
 

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

⮝ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

✆ +91 9607365656

mailto:sales@maximizemarketresearch.com

https://www.maximizemarketresearch.com


kalpesh rajput

108 Blog posts

Comments